Showing results (61-70 of 114) with videos related to
Sort By:
Pageof 12
International Journal of Clinical Pharmacology Research|January 1, 1984
Changed plasma prolactin levels after etoperidone and placeboG Meco, M Casacchia, B Boni, et al.Parkinsonism & Related Disorders|December 1, 2009
Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic reviewL Correia Guedes, J J Ferreira, M M Rosa, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2003
Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7V Bonifati, M C J Dekker, N Vanacore, et al.Stroke Research and Treatment|January 15, 2013
Walking training with foot drop stimulator controlled by a tilt sensor to improve walking outcomes: a randomized controlled pilot study in patients with stroke in subacute phaseG Morone, A Fusco, P Di Capua, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 12, 2002
Donepezil in the treatment of hallucinations and delusions in Parkinson's diseaseG Fabbrini, P Barbanti, C Aurilia, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2003
PARK6 is a common cause of familial parkinsonismE M Valente, F Brancati, V Caputo, et al.Disability and Rehabilitation|October 30, 1998
Prognostic factors in rehabilitation of above knee amputees for vascular diseasesM Traballesi, S Brunelli, L Pratesi, et al.European Journal of Histochemistry : EJH|January 1, 1997
Effects of cocaine treatment on the nervous system of planaria (Dugesia gonocephala s. l.). Histochemical and ultrastructural observationsV Margotta, B Caronti, G Meco, et al.Cephalalgia : an International Journal of Headache|February 13, 2001
Dopamine and migraine: does Parkinson's disease modify migraine course?P Barbanti, G Fabbrini, N Vanacore, et al.Pharmacopsychiatry|July 1, 1984
A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitorM Casacchia, A Carolei, C Barba, et al.Pageof 12